UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s Telephone Number, Including Area Code: |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of Matters to a Vote of Security Holders.
On May 24, 2024, Allakos Inc. (the “Company”) held its 2024 Annual Meeting of Stockholders (“2024 Annual Meeting”). At the 2024 Annual Meeting, the Company’s stockholders voted on three proposals, each of which is described in more detail in the Company’s proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 23, 2024. There were 88,544,474 shares of the Company’s common stock outstanding as of March 28, 2024, the record date for the determination of the stockholders entitled to notice of, and to vote at, the 2024 Annual Meeting. A total of 78,358,216 shares were present in person or by proxy at the 2024 Annual Meeting, representing 88.50% of the outstanding common stock entitled to vote. The voting results are presented below.
Proposal 1: Election of Directors
The Company’s stockholders elected each of the following nominees to serve as a Class III director of the Company for a three-year term expiring at the Company’s 2027 Annual Meeting of Stockholders, or until such director’s successor is duly elected and qualified, or until his/her earlier death, resignation, disqualification or removal.
Nominees |
|
For |
|
|
Withheld |
|
|
Broker Non-Votes |
|
|||
Robert E. Andreatta |
|
|
63,998,665 |
|
|
|
3,369,358 |
|
|
|
10,990,193 |
|
Dolca Thomas, M.D. |
|
|
67,100,639 |
|
|
|
269,018 |
|
|
|
10,988,559 |
|
Proposal 2: Ratification of Independent Registered Public Accounting Firm
The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024.
For |
|
|
Against |
|
|
Abstain |
|
|
Broker Non-Votes |
|
||||
|
77,964,435 |
|
|
|
201,926 |
|
|
|
191,855 |
|
|
|
— |
|
Proposal 3: Advisory Vote on Named Executive Officer Compensation
The Company’s stockholders approved, on an advisory non-binding basis, the compensation of the Company's named executive officers.
For |
|
|
Against |
|
|
Abstain |
|
|
Broker Non-Votes |
|
||||
|
57,581,186 |
|
|
|
9,731,502 |
|
|
|
56,969 |
|
|
|
10,988,559 |
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
Allakos Inc. |
|
|
|
|
Date: |
May 28, 2024 |
By: |
/s/ H. Baird Radford, III |
|
|
|
H. Baird Radford, III |